
John F. Kuckelman
John F. Kuckelman is the legal director at Novo Nordisk, a leading global healthcare company specializing in diabetes care and chronic disease management. He recently made headlines by addressing the company's decision to sue competitor Eli Lilly for allegedly misleading marketing practices concerning their weight loss medications, asserting that pharmaceutical companies have a responsibility to provide accurate and truthful information in their public claims.
Power1,601
Reach37,517
Country presence
Recent news mentions
John F. Kuckelman is the senior vice president and group general counsel for Novo Nordisk.
Ozempic-maker Novo Nordisk sues rival Eli Lilly, accusing it of false advertisingBBC·
United Kingdom· 2026-07-21
John F. Kuckelman is the legal director at Novo Nordisk.
Novo sagsøger konkurrent for vildledende markedsføringPolitiken·
Denmark· 2026-07-21

